News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
161 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17664)
Month
January (2721)
February (3480)
March (4381)
April (4039)
May (4871)
June (4841)
July (3188)
August (2609)
September (3140)
October (3520)
November (2936)
December (2392)
Day
1 (177)
2 (112)
5 (165)
6 (173)
7 (164)
8 (144)
9 (108)
12 (122)
13 (163)
14 (156)
15 (173)
16 (114)
19 (177)
20 (181)
21 (203)
22 (192)
23 (126)
26 (160)
27 (196)
28 (170)
29 (183)
30 (161)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
5
6
7
8
9
12
13
14
15
16
19
20
21
22
23
26
27
28
29
30
Drug Development
NovaBay Pharmaceuticals, Inc. (formerly known as NovaCal Pharmaceuticals, Inc.)'s Aganocides Show Penetration and Efficacy in a Pre-Clinical Infected Human Nail Model of Onychomycosis
October 30, 2009
·
1 min read
Business
Sanofi-Aventis (France) Video Q&A: CEO Chris Viehbacher Comments on Q3 ’09 Earning and Outlook
October 30, 2009
·
1 min read
Biotech Bay
ARYx Therapeutics, Inc. to Present at the Oppenheimer Annual Healthcare Conference
October 30, 2009
·
1 min read
Sangui BioTech International Inc.: Tamaulipas Comparative Wound Healing Test Treatment Successfully Concluded
October 30, 2009
·
2 min read
BioForest
SemBioSys Genetics Inc. Enters in Non-Dilutive Financing Plan of Arrangement
October 30, 2009
·
4 min read
Biotech Bay
NeurogesX, Inc. to Present at Two November Conferences
October 30, 2009
·
2 min read
Genetown
Momenta Pharmaceuticals, Inc. to Present at the Oppenheimer 20th Annual Healthcare Conference
October 30, 2009
·
1 min read
Business
Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics
October 30, 2009
·
2 min read
Business
Innospec Reports Third Quarter Financial Results
October 30, 2009
·
1 min read
Genetown
Generex Biotechnology Corporation Announces That It Will Not Exercise Its Rights to Issue and Sell Stock Under Its At Market Issuance Sales Agreement With WM Smith Until Further Notice
October 30, 2009
·
1 min read
Previous
10 of 17
Next